Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs U.S. Peptic Ulcer Therapeutics and Helicobacter pylori Diagnostics Markets
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

U.S. Peptic Ulcer Therapeutics and Helicobacter pylori Diagnostics Markets

DateAug, 1998
Pages0
Price / format€2599 / Hard Copy
€2223 / Site License
€3353 / Enterprisewide

€2 204 





Abstract:



Experts estimate that 25 million people in the United States suffer from peptic ulcer disease but that only 20 percent see a doctor and are diagnosed. These numbers must change if manufacturers and vendors of ulcer therapeutics and diagnostics products want to exploit the U.S. market's full potential. This Frost & Sullivan report offers an objective look at each peptic ulcer therapeutics product category and highlights crucial trends and competitive issues in the marketplace. It examines rapid microbiology tests and breath urea tests for detecting H. pylori, pinpointing where your company should focus its resources for expansion.











Table of contents:
- Executive Summary

- Introduction to U.S. Peptic Ulcer Therapeutics and H. pylori Diagnostics Market

- Summary of Major Findings

- Industry Challenges

- Challenges Facing the Pharmaceutical Industry

- Frost & Sullivan's 12-Step Market Engineering Research Methodology

- Market Engineering Forecasting Methodology

- Market Engineering Measurement Analysis of the Peptic Ulcer Therapeutics and H. pylori Diagnostics Industry

- Market Overview and Definitions

- Presentation of Strategic Significance of Measurements

- Market Engineering Research for the U.S. Helicobacter pylori Diagnostic Tests Market

- Strategic Analysis and Forecasts of the Total Market

- Strategic Analysis and Forecasts of the U.S. H. pylori Rapid Microbiology Tests Market

- Strategic Analysis and Forecasts of the H. pylori Breath Urea Tests Market

- Market Engineering Research for the U.S. Peptic Ulcer Disease Therapeutics Market

- Strategic Analysis and Forecasts of the Total Market

- Strategic Analysis and Forecasts of the H2 Receptor Market

- Strategic Analysis and Forecasts of the Proton Pump Inhibitors Market

- Strategic Analysis and Forecasts of the H. pylori-Specific Peptic Ulcer Market

- Strategic Analysis and Forecasts of Other Peptic Ulcer Disease Therapies Market

- Key Strategies Used by the Industry

- Introduction

- Marketing Department

- Sales Department

- Research and Development

- Business Development

- The Role of Market Engineering in the Healthcare Industry

- Integrating Market Engineering into Business Planning

- Using Market Engineering to Address Industry Challenges, Market Trends, and Opportunities

- Implementation of Market Engineering in the Corporate Structure

- Market Engineering Monitoring of the Healthcare Industry

- Profiles of Strategically Targeted Companies

- Abbott Laboratories (847) 937-6100

- American Home Products (973) 683-2000

- Astra Pharmaceuticals (610) 695-1000

- Biomerica, Inc. (949) 645-2111

- ChemTrak, Inc. (408) 773-8156

- Johnson & Johnson (732) 524-0400

- Meridian Diagnostics, Inc. (513) 271-3700

- OraVax, Inc. (617) 494-1339

- Quidel Corporation (619) 552-1100

- Database of Key Industry Participants

- Market Participants

- Related Companies

- Distributors

- Organizations and Trade Associations

- Table of Figures

- Table of Charts









Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found



Add New Buy/Sell Lead